Claire Mazumdar
Chief Executive Officer at Bicara Therapeutics · 17 reported transactions in 1 company · latest trade Aug 10, 2026
Their trades
Sold | Aug 10, 2026 | Aug 10, 2026 close $27.73 → Oct 29, 2026 close $9.73. S&P 500 −0.5% over the same days. | ||
Sold | Jul 10, 2026 | Jul 10, 2026 close $28.91 → Oct 29, 2026 close $9.73. S&P 500 +1.9% over the same days. | ||
Sold | Jul 10, 2026 | Jul 10, 2026 close $28.91 → Oct 29, 2026 close $9.73. S&P 500 +1.9% over the same days. | ||
Sold | May 18, 2026 | May 18, 2026 close $19.29 → Oct 29, 2026 close $9.73. S&P 500 +4.2% over the same days. | ||
Sold | May 18, 2026 | May 18, 2026 close $19.29 → Oct 29, 2026 close $9.73. S&P 500 +4.2% over the same days. | ||
Sold | Nov 24, 2025 | Nov 24, 2025 close $18.88 → Oct 29, 2026 close $9.73. S&P 500 +15.1% over the same days. |
$279.8K
Aug 10, 2026 close $27.73 → Oct 29, 2026 close $9.73. S&P 500 −0.5% over the same days.
$831.04
Jul 10, 2026 close $28.91 → Oct 29, 2026 close $9.73. S&P 500 +1.9% over the same days.
$283.4K
Jul 10, 2026 close $28.91 → Oct 29, 2026 close $9.73. S&P 500 +1.9% over the same days.
$60.6K
May 18, 2026 close $19.29 → Oct 29, 2026 close $9.73. S&P 500 +4.2% over the same days.
$240K
May 18, 2026 close $19.29 → Oct 29, 2026 close $9.73. S&P 500 +4.2% over the same days.
$776.4K
Nov 24, 2025 close $18.88 → Oct 29, 2026 close $9.73. S&P 500 +15.1% over the same days.